Medicine & Life Sciences
Pulmonary Arterial Hypertension
100%
Safety-net Providers
76%
ambrisentan
73%
treprostinil
70%
Sepsis
68%
Endothelin A Receptors
57%
Patient Readmission
48%
Lung Diseases
45%
Pandemics
45%
Occupational Groups
42%
Pulmonary Hypertension
42%
Critical Illness
39%
Cross Infection
34%
Hand Hygiene
33%
Mental Health
33%
Chronic Disease
31%
Disasters
27%
Delivery of Health Care
25%
Odds Ratio
23%
Infections
23%
Hospitalization
22%
Confidence Intervals
21%
Catheter-Related Infections
21%
Surgical Wound Infection
19%
Survivors
18%
Hemodynamics
17%
Transaminases
17%
Vascular Resistance
17%
Therapeutics
16%
Epoprostenol
16%
Mortality
16%
Urinary Tract Infections
16%
Vascular Access Devices
15%
Vasoconstriction
14%
Edema
13%
Motivation
13%
Hospital Emergency Service
13%
Patient Care Bundles
13%
Catheters
13%
Critical Care
12%
Bacteremia
12%
Catheterization
11%
Clinical Decision Support Systems
11%
Safety Management
10%
Health Care Process Assessment
10%
Placebos
10%
Endothelins
9%
Mental Disorders
9%
Liver Function Tests
9%
Social Sciences
reform
25%
hygiene
22%
incentive payments
22%
Healthcare
21%
mortality
17%
personnel
10%
clinical decisions
8%
Medical records
8%
clinician
6%
campaign
5%
manager
5%